newsfilter
← Latest News
FDA Approved Drugs·

Approval of Margenza, Bla #761150

Approval Date: 01/15/2025; Drug Name: Margenza, Bla #761150; Active Ingredients: MARGETUXIMAB-CMKB; Company: Macrogenics Inc; Submission Status: Approval; Application Number: 761150

Company
MACROGENICS INC
Keywords
MACROGENICS INC